Diabetes Fact Sheet in Korea 2021
Jae Hyun Bae1, Kyung-Do Han2, Seung-Hyun Ko3
1Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Diabetes & Metabolism Journal
|June 3, 2022
Summary
The prevalence of diabetes mellitus in Korean adults is high, with only 9.7% achieving all major health goals. Improved national diabetes awareness and comprehensive care are crucial for better management.
Area of Science:
- Endocrinology
- Public Health
- Epidemiology
Background:
- Diabetes mellitus prevalence and management are significant public health concerns in Korea.
- Understanding risk factors, comorbidities, and self-management is vital for effective diabetes care.
Purpose of the Study:
- To investigate the prevalence and management of diabetes mellitus in Korean adults.
- To assess risk-factor control, comorbidities, and self-management behaviors.
- To analyze antidiabetic medication use over time.
Main Methods:
- Cross-sectional analysis of the Korea National Health and Nutrition Examination Survey (2019-2020).
- Analysis of Korean National Health Insurance Service data (2002-2018) for medication use.
- Assessment of diabetes mellitus prevalence, treatment, risk factors, comorbidities, and self-management.
Main Results:
- Diabetes mellitus prevalence was 16.7% in Korean adults (≥30 years) in 2020.
- Only 24.5% achieved glycosylated hemoglobin (HbA1c) <6.5%, and 9.7% met all glycemic, blood pressure, and lipid control goals.
- Self-management behaviors were less common in men, and 16.7% of adults with diabetes had excess energy intake.
Conclusions:
- The high prevalence of diabetes mellitus in Korea necessitates continuous monitoring and national efforts.
- Achieving comprehensive control of glycemic, blood pressure, and lipid levels remains a challenge for most patients.
- Improving public awareness and enhancing comprehensive diabetes care strategies are essential.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
719
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
719
Pathophysiology of Diabetes
1.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.3K
Diabetes: Management and Pharmacotherapy
415
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
415
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Hormones Regulating Blood Glucose
4.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.1K


